U.S. Beverage Stock News

NYSE:GPGI
NYSE:GPGITech

Is GPGI (GPGI) Share Price Outrunning Fundamentals After Recent Volatility?

If you are wondering whether GPGI is attractively priced or already reflecting a lot of optimism, the current share price at US$17.06 raises some useful questions about what you are really paying for. Recent returns are mixed, with the stock up 3.3% over the last week but showing a 27.4% decline over 30 days, an 8.6% decline year to date, and gains of 51.0% over 1 year, 191.8% over 3 years, and 114.8% over 5 years. These moves sit against a backdrop of ongoing coverage that keeps GPGI on...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

LivaNova’s Aura6000 FDA Win Reshapes Obstructive Sleep Apnea Opportunity

FDA grants premarket approval to LivaNova's aura6000 System for adult patients with moderate to severe Obstructive Sleep Apnea who do not benefit from standard therapies. The system uses proximal hypoglossal nerve stimulation and is supported by clinical trial data showing meaningful outcomes, including in harder to treat patient groups. LivaNova (NasdaqGS:LIVN) also discloses work on a next generation, MRI compatible version of the aura6000 with additional features. LivaNova, listed on...
NasdaqGM:RICK
NasdaqGM:RICKHospitality

RCI Hospitality Holdings (RICK) One Off US$5.2m Loss Tests Bullish Earnings Narrative

RCI Hospitality Holdings (RICK) FY 2025 earnings at a glance RCI Hospitality Holdings (RICK) has just posted its FY 2025 numbers with Q4 revenue of US$70.9 million and a basic EPS loss of US$0.63, set against trailing 12 month EPS of US$1.23 on revenue of US$279.4 million and earnings growth of 259.1% for the period. Over recent quarters, revenue has moved from US$73.2 million in Q4 2024 to US$71.5 million in Q1 2025, US$65.9 million in Q2, US$71.1 million in Q3 and US$70.9 million in Q4,...
NYSE:BOBS
NYSE:BOBSSpecialty Retail

Is Bob's Discount Furniture (BOBS) Pricing Error Or Opportunity After Recent Share Price Slump

Wondering whether Bob's Discount Furniture is a bargain or a value trap at around US$12.49? This article breaks down what the current price might be implying about the business. The stock has seen sharp recent moves, with a 7 day return of an 18.9% decline and a 30 day return of a 37.2% decline, while the year to date return sits at a 26.6% decline. These swings have put Bob's Discount Furniture back on the radar for investors who are reassessing what they are willing to pay for retailers...
NYSE:ESI
NYSE:ESIChemicals

Is It Time To Reassess Element Solutions (ESI) After Recent Materials Sector Re Rating?

To understand whether Element Solutions might still offer value at its recent price, you need to see how its fundamentals compare with what the market is currently paying. Over shorter periods, the stock has been mixed, with a 0.2% return over the last week, a 7.9% decline over the last month, a 19.7% gain year to date and a 24.5% return over the last year, alongside 75.2% and 78.7% returns across the past 3 and 5 years respectively. Recent news flow has highlighted Element Solutions in the...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

Is It Too Late To Consider LeMaitre Vascular (LMAT) After Its Recent Share Price Surge?

If you are wondering whether LeMaitre Vascular at around US$106 a share still offers value, you are not alone. A closer look at what that price really reflects can be useful. The stock has returned 17.3% over the last 30 days, 32.6% year to date and 28.5% over the past year, which may signal that expectations and perceived risk are shifting. Recent attention on LeMaitre Vascular has centered on how the company is positioned within medical devices and vascular care solutions, as investors...
NYSE:DHT
NYSE:DHTOil and Gas

DHT Holdings (DHT) Margin Strength Challenges Bearish Revenue Concerns In FY 2025 Results

DHT Holdings (DHT) has wrapped up FY 2025 with fourth quarter revenue of US$144.2 million and basic EPS of US$0.41, while trailing twelve month figures sit at US$551.3 million of revenue and EPS of US$1.31, underpinned by earnings growth of 16.4% over the last year. Over recent periods, quarterly revenue has moved between US$123.0 million and US$145.8 million, with basic EPS ranging from US$0.22 to US$0.41. Trailing net profit margin has improved from 31.7% to 38.3%, setting the stage for...
NYSE:ETR
NYSE:ETRElectric Utilities

Entergy Community Efforts Add Context For Dividend And Valuation Story

Entergy highlighted its support for workforce development and community resilience at the Dress for Success New Orleans event. Company leaders and employees participated in the event, underscoring involvement in local career readiness efforts. For investors watching Entergy (NYSE:ETR), this kind of community engagement sits alongside a share price of $99.9 and a value score of 3. The stock has seen a 6.4% return year to date and a 22.4% return over the past year, which gives added context...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Axcelis Targets China With Purion Launch And CS Asia Spotlight

Axcelis Technologies (NasdaqGS: ACLS) will serve as the Diamond Sponsor of the Compound Semiconductor Asia Conference (CS Asia) 2026 during SEMICON China. The company plans to launch its next generation Purion Power Series+ Platform for chipmakers in China at the event. Axcelis CEO Mary Puma is scheduled to deliver a keynote address to industry participants and customers. Axcelis Technologies focuses on ion implantation and related processing equipment for the semiconductor sector, with...
NYSE:GSL
NYSE:GSLShipping

Global Ship Lease Shelf Plan And Report Highlight Fleet Growth And Valuation

Global Ship Lease (NYSE:GSL) files a new US$229 million Shelf Registration. The company also publishes its 2025 Annual Report, covering recent fleet acquisitions and charter activity. Both filings offer fresh detail on capital plans, fleet growth, and charter coverage for the year ahead. Global Ship Lease focuses on owning and chartering containerships, so its funding plans and fleet moves matter directly for earnings power and balance sheet risk. The new US$229 million Shelf Registration...
NasdaqCM:SLS
NasdaqCM:SLSBiotechs

SELLAS Life Sciences’ AML Pipeline Adds Key Clinical Checkpoints For Investors

SELLAS Life Sciences Group (NasdaqCM:SLS) has begun a Phase 2 trial of SLS009 in first line acute myeloid leukemia (AML), targeting high risk patient subgroups. The company plans to present new preclinical data for SLS009, including activity in difficult to treat AML mutations, at an upcoming AACR meeting. SELLAS is progressing toward the final analysis of the Phase 3 REGAL trial of its GPS cancer vaccine in AML, with trial oversight ongoing and positive trends in patient outcomes...
NasdaqCM:FUFU
NasdaqCM:FUFUSoftware

BitFuFu (FUFU) Trailing Profit Flip To US$57.5m Loss Tests Bullish Earnings Narrative

BitFuFu (NasdaqCM:FUFU) closed out FY 2025 with Q4 revenue of US$101.7 million and a basic EPS loss of US$0.60, compared with Q4 FY 2024 revenue of US$99.2 million and EPS of US$0.14. Trailing twelve month EPS for Q4 stood at a loss of US$0.35 on revenue of US$475.8 million. Over the past year, quarterly revenue has ranged from US$78.0 million to US$180.7 million and quarterly basic EPS has swung between a loss of US$0.60 and a profit of US$0.29, underscoring how sensitive profitability...
NYSE:SITE
NYSE:SITETrade Distributors

Is It Time To Reassess SiteOne (SITE) After Recent Share Price Volatility?

If you are wondering whether SiteOne Landscape Supply at around US$127 per share looks expensive, cheap, or somewhere in between, this article focuses squarely on what the current price implies about its value. The stock has been volatile recently, with a 1.8% decline over the past week, a 16.4% decline over the past month, a 1.9% gain year to date, and a 4.5% return over the last year. Recent coverage has centered on how SiteOne sits within the broader Trade Distributors space and what that...
NYSEAM:OZ
NYSEAM:OZReal Estate

Belpointe PREP (OZ) Posts US$40 Million TTM Loss Challenging Bullish Narratives

Belpointe PREP (OZ) just reported its FY 2025 numbers with Q4 total revenue of about US$3.1 million and a basic EPS loss of US$2.96, set against a trailing twelve month loss of US$10.17 per share on revenue of roughly US$9.2 million. Over the last six quarters, total revenue has moved from about US$0.86 million in Q3 2024 to US$3.06 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$1.85 per share to a loss of US$3.12. This leaves investors focused on how much of that...
NasdaqGS:MQ
NasdaqGS:MQDiversified Financial

Is It Time To Reassess Marqeta (MQ) After Recent Fintech Product Updates?

Wondering whether Marqeta at around US$4.08 is a bargain or a value trap right now? This article breaks down what the current price actually reflects. The stock has moved 2.8% over the past week, is flat over 30 days, and is showing a 12.1% decline year to date with a 7.7% decline over the last year but a 14.3% gain across three years. This gives mixed signals about how the market is treating the story. Recent company updates and product announcements in the payments space have kept Marqeta...
NYSEAM:STRW
NYSEAM:STRWHealth Care REITs

Strawberry Fields REIT (STRW) FFO Growth Outpaces Revenue And Reinforces Efficiency Narrative

Strawberry Fields REIT (STRW) just closed FY 2025 with fourth quarter revenue of US$40.1 million, basic EPS of US$0.15 and funds from operations of US$20.6 million, with trailing twelve month revenue at US$155.0 million and EPS at US$0.60 as profitability metrics moved up from a 3.5% to a 4.9% net margin and trailing earnings expanded 85% over the past year. Over that period, the REIT has seen revenue progress from US$117.1 million to US$155.0 million on a trailing basis, while net income,...
NasdaqGM:ETON
NasdaqGM:ETONPharmaceuticals

Eton Pharmaceuticals (ETON) Turns Q4 Profit As Trailing Losses Test Bullish Growth Narrative

Eton Pharmaceuticals (ETON) just posted its FY 2025 Q4 numbers with revenue of US$21.3 million and Basic EPS of US$0.06, while the trailing twelve months show revenue of US$80.0 million and a Basic EPS loss of US$0.17. Over recent quarters, the company has seen quarterly revenue move from US$11.6 million in Q4 2024 to US$21.3 million in Q4 2025, alongside Basic EPS shifting from a loss of US$0.02 in Q4 2024 to a profit of US$0.06 in Q4 2025. This sets up a results season where investors will...
NasdaqGS:CSIQ
NasdaqGS:CSIQSemiconductor

Canadian Solar (CSIQ) Q4 EPS Loss Reinforces Bearish Margin Narrative

Canadian Solar (CSIQ) has capped FY 2025 with fourth quarter revenue of US$1.2 billion and a basic EPS loss of US$1.28, as net income excluding extra items came in at a loss of US$86.3 million, putting the spotlight firmly on profitability rather than top line scale. Over recent quarters, the company has seen revenue move between US$1.2 billion and US$1.7 billion, with basic EPS swinging from a profit of US$0.51 in Q4 2024 to a loss in Q4 2025. This sets up a results season where margin...
NasdaqGS:ALMS
NasdaqGS:ALMSPharmaceuticals

Alumis (ALMS) Q4 Loss Of US$92.9 Million Tests Bullish Growth Narrative

Alumis (ALMS) has just wrapped up FY 2025 with Q4 revenue of US$1.9 million, a basic EPS loss of US$0.89 per share, and a net loss of US$92.9 million. On a trailing twelve month basis, revenue was US$24.1 million, with a basic EPS loss of US$2.86 per share and a net loss of US$243.3 million. Over recent quarters, revenue moved from US$17.4 million in Q1 2025 to US$2.7 million in Q2, US$2.1 million in Q3, and US$1.9 million in Q4. EPS shifted from a loss of US$1.82 in Q1 to a profit of US$0.78...
NYSE:FBIN
NYSE:FBINBuilding

Fortune Brands Leadership Shakeup And Activist Deal Test Turnaround Prospects

Fortune Brands Innovations (NYSE:FBIN) has appointed an interim CEO and an interim CFO while launching a formal search for a permanent chief executive. The company reached a governance cooperation agreement with activist investor Ed Garden, who has joined the board of directors. The board plans to phase out its classified structure, following internal leadership changes and shareholder pressure that appear aimed at avoiding a proxy fight. For investors watching NYSE:FBIN, these leadership...
NasdaqGS:ASMB
NasdaqGS:ASMBBiotechs

Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives

Assembly Biosciences (ASMB) just closed FY 2025 with Q4 revenue of US$42.5 million and basic EPS of US$1.30, alongside trailing twelve month revenue of US$72.3 million and a trailing EPS loss of US$0.55. Over recent quarters the company has seen revenue move from US$7.4 million and an EPS loss of US$1.58 in Q4 FY 2024 to US$42.5 million and EPS of US$1.30 in Q4 FY 2025, while trailing twelve month net income narrowed to a loss of US$6.1 million. This sets up a results season where investors...
NYSEAM:GROY
NYSEAM:GROYMetals and Mining

Gold Royalty’s Cash Flow Turnaround Tests Market Pullback And Valuation Gap

Gold Royalty (NYSEAM:GROY) recently reported three consecutive quarters of positive free cash flow, which management has described as a financial inflection point. The company reported record annual revenue and cash flow, alongside a shift to a zero-debt capital structure after equitizing debt and completing a major equity raise. Gold Royalty expanded its portfolio with a new royalty on BHP's Pedra Branca mine, adding exposure to an operating asset. Gold Royalty, which last closed at $3.15,...
NYSE:DINO
NYSE:DINOOil and Gas

HF Sinclair Dual Executive Exit Puts Governance And Valuation In Focus

HF Sinclair plans a permanent separation with its CEO and CFO following their voluntary leaves. The company is working toward final separation agreements as part of an ongoing internal review. The dual executive exit comes during a period of growth that includes joint ventures and other initiatives. For HF Sinclair (NYSE:DINO), this leadership change comes at a time when the stock has seen strong recent performance, with shares at $60.22 and a 28.5% return year to date. The stock is up 8.1%...
NYSE:ZKH
NYSE:ZKHTrade Distributors

ZKH Group (NYSE:ZKH) Turns Quarterly Profit As Loss Reduction Narrative Faces New Test

ZKH Group (NYSE:ZKH) closed FY 2025 with fourth quarter revenue of C¥2,557.2 million and basic EPS of C¥0.03, set against trailing twelve month revenue of C¥8,987.7 million and a net loss of C¥139.7 million. Over the past six reported quarters, revenue has ranged between C¥1,935.4 million and C¥2,557.2 million, while basic EPS has moved from a loss of C¥0.50 in Q3 2024 to a small profit in Q4 2025. This leaves investors focused on how efficiently that top line is translating into earnings...